OchoaSConstantineGMLionakisMS.Genetic susceptibility to fungal infection in children. Curr Opin Pediatr. 2020;32(6):780-789.
2.
OkadaSAsanoTMoriyaK, et al. Human STAT1 gain-of-function heterozygous mutations: chronic mucocutaneous candidiasis and type I interferonopathy. J Clin Immunol. 2020;40(8):1065-1081.
3.
IvashkivLB.IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol. 2018;18(9):545-558.
4.
ZhangWChenXGaoG, et al. Clinical relevance of gain-and loss-of-function germline mutations in STAT1: a systematic review. Front Immunol. 2021;12:654406.
5.
TabelliniGVairoDScomodonO, et al. Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations. J Allergy Clin Immunol. 2017;140(2):553-564.
6.
AbersMSLionakisMS.Chronic mucocutaneous candidiasis and invasive fungal infection susceptibility. In SullivanKStiehmER, eds. Stiehm’s Immune Deficiencies. Academic Press, Cambridge, MA. 2020:961-989.
7.
RombergNMorbachHLawrenceMG, et al. Gain-of-function STAT1 mutations are associated with PD-L1 overexpression and a defect in B-cell survival. J Allergy Clin Immunol. 2013;131(6):1691-1693.
8.
CareyBLambourneJPorterSHodgsonT.Chronic mucocutaneous candidiasis due to gain-of-function mutation in STAT 1. Oral Diseases. 2019;25(3):684-692.
9.
ToubianaJOkadaSHillerJ, et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood. 2016;127(25):3154-3164.
10.
OdekCKendirliTDoğuF, et al. Patients with primary immunodeficiencies in pediatric intensive care unit: outcomes and mortality-related risk factors. J Clin Immunol. 2014;34(3):309-315.
11.
SuavinhoÉde NápolisACSegundoGR.Primary immunodeficiency investigation in patients during and after hospitalization in a pediatric intensive care unit. Rev Paul Pediatr. 2014;32:32-36.
12.
TangyeSGAl-HerzWBousfihaA, et al. The ever-increasing array of novel inborn errors of immunity: an interim update by the IUIS committee. J Clin Immunol. 2021;41(3):666-679.
13.
LeidingJWOkadaSHaginD, et al. Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations. J Allergy Clin Immunol. 2018;141(2):704-717.e5.
